Could a new type of weight-loss pill shake up the market? Here’s what to know about orforglipron

By Martin Whyte, Associate Professor of Metabolic Medicine, University of Surrey

A new type of daily pill has proven more effective for weight loss and blood sugar control than its currently available counterparts, according to a recent trial. The drug, known as orforglipron, could be a game-changer in the rapidly expanding oral weight-loss drug market.

The advent of the injectable weight-loss drug semaglutide (known better by its brand names Wegovy and Ozempic) marked a distinct shift in the weight-loss drugs market when it became available just a few years ago.

Semaglutide is a class of glucagon-like peptide-1 (GLP-1) medication. These drugs mimic…

Read complete article

~	Celluloid: the story of the plastic that made Hollywood

~	If using ChatGPT is cheating, what about ghostwriting? The old debate behind a new panic

~	Anthrax-causing bacteria have dwelled in soil for centuries – cycling through people, animals and earth

~	Pittsburgh’s post-steel economy is a success – and a warning for other cities

~	Food aid doesn’t make people loafers – research shows government benefits help low-income people find jobs

~	A connection to nature fuels well-being worldwide, according to a study of 38,000 people

~	Teens are driving the demand for online abortion pills via telehealth – new research

~	New federal student loan limits affect social work graduate students, with impacts for survivors of domestic violence in Colorado and elsewhere

~	Jürgen Habermas: a philosopher whose hopes for a better future are more important than ever

~	On Passover, some Sephardic Jews revisit not only the story of their ancestors, but also their Ladino language